|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,327.60 INR | -1.78% |
|
+4.32% | -1.34% |
Sales 2026 by Business Segment
Sales 2026 by Geography
Historical Breakdown of Revenue by Business Segments
: Breakdown by Business Segment
| Fiscal Period: March | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
Pharmaceutical Products | |||||||
Manufacturing and trading in pharmaceutical products | 712.93Cr | 853.17Cr | 1.02TCr | 1.2TCr | - | ||
Total Assets | 1.31TCr | 1.51TCr | 1.7TCr | 2.03TCr | - | ||
Interest Expense | -5.48Cr | -4.51Cr | -2.55Cr | -52.93L | - | ||
Income Tax Expense | 63Cr | 82Cr | 104.46Cr | 122.91Cr | - | ||
CAPEX | -155.5Cr | -145.08Cr | -86Cr | -111.17Cr | - | ||
EBT | 237.52Cr | 322.01Cr | 412.56Cr | 494.55Cr | - | ||
D&A | 50Cr | 54Cr | 54Cr | 54Cr | - | ||
Net Income | 174.93Cr | 240.09Cr | 308.1Cr | 371.64Cr | - |
Geographical Revenue Distribution History
| Fiscal Period: March | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
Others | 244.07Cr | 273.78Cr | 374.75Cr | 400.28Cr | - | ||
Total Assets | - | - | 2.06Cr | 66.52L | - | ||
America | 131.45Cr | 147.25Cr | 107.98Cr | 137.97Cr | - | ||
India | 337.41Cr | 432.13Cr | 534.21Cr | 661.83Cr | - | ||
Total Assets | 677.38Cr | 773.3Cr | 794.78Cr | 875.93Cr | - |
- Stock Market
- Stocks
- CONCORDBIO Stock
- Financials Concord Biotech Limited
- Business Segments
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition